Arbiter Partners Capital Management LLC Makes New $14.83 Million Investment in Grail, Inc. (NASDAQ:GRAL)

Arbiter Partners Capital Management LLC purchased a new position in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 830,642 shares of the company's stock, valued at approximately $14,827,000. Grail accounts for about 9.2% of Arbiter Partners Capital Management LLC's holdings, making the stock its largest holding. Arbiter Partners Capital Management LLC owned 2.47% of Grail as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GRAL. Crcm LP bought a new position in shares of Grail during the 4th quarter worth $65,061,000. Primecap Management Co. CA purchased a new stake in Grail in the fourth quarter worth about $37,118,000. Vanguard Group Inc. bought a new position in Grail during the 4th quarter worth about $25,902,000. Geode Capital Management LLC purchased a new position in Grail during the 4th quarter valued at about $7,920,000. Finally, Bank of New York Mellon Corp purchased a new position in Grail during the 4th quarter valued at about $6,262,000.

Grail Trading Up 2.2 %

Shares of GRAL traded up $0.51 during trading hours on Friday, hitting $23.26. The company had a trading volume of 1,024,682 shares, compared to its average volume of 1,226,001. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99. The company's fifty day moving average price is $33.52 and its two-hundred day moving average price is $23.20.

Grail (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. As a group, equities research analysts anticipate that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Remove Ads

Analyst Upgrades and Downgrades

Separately, Morgan Stanley increased their price objective on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th.

Insider Transactions at Grail

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. This trade represents a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the transaction, the president now directly owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock valued at $360,436 in the last 90 days.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.